Diagnostics
Diagnostics companies are building the infrastructure precision medicine runs on. The product to launch, the channel to lead with, the indication to anchor a development pipeline, the category to enter next, the growth strategy when the core market matures — these are the decisions that determine where a Dx company wins, how it reaches its market, and which categories are worth building for.

Select Capabilities
Selected Work

New Prenatal Opportunity Assessment
Voice-of-Customer Research
Go-to-Market Strategy

MRD Monitoring Market Assessment and Strategy
Biomarker and Diagnostics Strategy
Go-to-Market Strategy
Market Landscaping and Sizing

Low-Throughput Molecular Diagnostic Testing Landscape Assessment
Voice-of-Customer Research
Competitive Analysis
Customer Segmentation






.png)
.png)



